Bitcoin Giant Strategy: Coinbase Among Shorted Stocks
A fresh look at how large holders deploy a bitcoin giant strategy and why Coinbase finds itself among the most shorte...
Which Cash Back Cards Have No Annual Fee
Uncover which cash back cards come with no annual fee. Choose the best option for your spending habits!
27,852 articles
Biotechnology's Chairman Board Sold: What Investors Know
Insider moves can shed light on a company’s trajectory, but they aren’t a crystal ball. This guide breaks down biotec...
New AI Winner Cheaper Than Anthropic Emerges in 2026
A lightweight but powerful AI platform is emerging as the newest winner cheaper than Anthropic, with early profitabil...
The Number That Sets Record on AI Chip Demand: $75B
NVIDIA posted a record-breaking $75.25 billion in Data Center revenue for its fiscal Q1 2027, a 92% year-over-year su...
Live: Will C3.AI (AI) Momentum After Earnings Tonight
C3.ai reports after the bell, with traders watching for signals on revenue, margins and AI platform uptake. This live...
Splitting Stocks: This Foundational Company Could Spark Rally
Stock splitting isn’t just a corporate stunt. It can shift trading dynamics, liquidity, and investor perception. This...
Nobody Knows Anything, SpaceX: IPO Edition for Investors
Investing headlines love bold predictions, but long-term numbers rarely align with hype. This guide uses SpaceX as a ...
Transcript: McKeel Hagerty, Chairman and Hagerty Insurance
From a tiny boat-insurer niche to a public company, Hagerty’s story is a case study in branding, community, and strat...
Cathie Wood Goes Bargain: 3 Stocks She Just Bought
Cathie Wood is famous for spotting disruptive growth. This guide breaks down what cathie wood goes bargain means and ...
QuantumScape Climbs Eagle Line Milestone
QuantumScape stock rallies on the Eagle Line milestone and early customer billings, signaling a shift from research t...
Ryan Specialty's Bought 6,300: What It Signals Investors
When a CFO buys a sizable block of shares, it can hint at confidence in the company’s future. This article breaks dow...
Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status